MiR-197 expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients

Gut and Liver

Volumn 7, Issue 3, 2013, Pages 335-342

  Chen, Li ^a   Li, Congzhi ^a   Peng, Zaiquan ^b   Zhao, Jinxiang ^b   Gong, Guozhong ^c   Tan, Deming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The Third Hospital of Changsha   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Interleukin 18; Liver failure; MicroRNAs; MiR 197

Indexed keywords

INTERLEUKIN 18; MESSENGER RNA; MICRORNA; MICRORNA 1246; MICRORNA 1305; MICRORNA 150; MICRORNA 185; MICRORNA 196B; MICRORNA 197; MICRORNA 223; MICRORNA 301A; MICRORNA 30A; MICRORNA 30D; MICRORNA 326; MICRORNA 328; MICRORNA 483 3P; MICRORNA 486 5P; MICRORNA 574 3P; MICRORNA 766; UNCLASSIFIED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84879342490     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2013.7.3.335     Document Type: Article

References (25)

1. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010;58:258-266.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
3. Bi Y, Liu G, Yang R. MicroRNAs: novel regulators during the immune response. J Cell Physiol 2009;218:467-472.
4. Qiu L, Fan H, Jin W, et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010;398:771-777.
5. Zhang X, Zhang E, Ma Z, et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by microRNA-1. Hepatology 2011;53:1476-1485.
6. Ura S, Honda M, Yamashita T, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009;49:1098-1112.
7. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-2545.
8. Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2005;13:881-891.
9. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi 2006;14:643-646.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408. (Pubitemid 34164012)
11. Otaegui D, Baranzini SE, Armañanzas R, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009;4:e6309.
12. Hoekstra M, van der Lans CA, Halvorsen B, et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010;394:792-797.
13. Pan XB, Ma H, Jin Q, Wei L. Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro. J Gastroenterol Hepatol 2012;27:805-812.
14. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082-5089.
15. Huang B, Zhao J, Lei Z, et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009;10:180-185.
16. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 2007;104:7080-7085. (Pubitemid 47186012)
17. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008;451:1125-1129. (Pubitemid 351317447)
18. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011;18:e242-e251.
19. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human microRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006;91:3584-3591. (Pubitemid 44402141)
20. Lehmann U, Streichert T, Otto B, et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010;10:109.
21. Estep M, Armistead D, Hossain N, et al. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010;32:487-497.
22. Arola-Arnal A, Bladé C. Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLoS One 2011;6:e25982.
23. Shinoda M, Wakabayashi G, Shimazu M, et al. Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2006;21:1731-1736. (Pubitemid 44410887)
24. Roth GA, Faybik P, Hetz H, et al. Pro-inflammatory interleukin-18 and caspase-1 serum levels in liver failure are unaffected by MARS treatment. Dig Liver Dis 2009;41:417-423.
25. Sun Y, Chen HY, Xin SJ. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines. Hepatobiliary Pancreat Dis Int 2004;3:230-234. (Pubitemid 38660156)